Search research articles
Contact Us
Filters
Showing results (221-230 of 493) with videos related to
Page
of 50
Sort By:
British Journal of Clinical Pharmacology
|
December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers
M Burnier, G A Turini, H R Brunner, et al.
Arthritis and Rheumatism
|
June 30, 2005
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis
Leen De Rycke, Dominique Baeten, Elli Kruithof, et al.
Drugs
|
November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis
Filip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Healthcare (Basel, Switzerland)
|
January 10, 2026
From Hidden Insights to Better Understanding: Physicians' Perspectives on Caregivers' Tacit Knowledge
Sylvia A Huisman, Kasper Kruithof, Maartje Hoogsteyns, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 24, 2010
Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo
Suzanne M Bal, Annelieke C Kruithof, Raphaël Zwier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1990
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells
J F Cajot, J Bamat, G E Bergonzelli, et al.
British Journal of Clinical Pharmacology
|
April 7, 2020
The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers
Sebastiaan C Goulooze, Annelieke C Kruithof, Shanavas Alikunju, et al.
Arthritis and Rheumatism
|
March 29, 2002
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy
Filip Van Den Bosch, Elli Kruithof, Dominique Baeten, et al.
Water Research
|
October 13, 2016
The role of natural organic matter in nitrite formation by LP-UV/H<sub>2</sub>O<sub>2</sub> treatment of nitrate-rich water
Sofia Semitsoglou-Tsiapou, Astrid Mous, Michael R Templeton, et al.
JACC. Basic to Translational Science
|
September 19, 2024
A New Ex Vivo Model to Study Cardiac Fibrosis in Whole Mouse Hearts
Boudewijn P T Kruithof, Babak Mousavi Gourabi, Arjanneke F van de Merbel, et al.
Page
of 50
Search research articles
Search
Showing results (221-230 of 493) with videos related to
Sort By:
Page
of 50
British Journal of Clinical Pharmacology
|
December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers
M Burnier, G A Turini, H R Brunner, et al.
Arthritis and Rheumatism
|
June 30, 2005
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis
Leen De Rycke, Dominique Baeten, Elli Kruithof, et al.
Drugs
|
November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis
Filip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Healthcare (Basel, Switzerland)
|
January 10, 2026
From Hidden Insights to Better Understanding: Physicians' Perspectives on Caregivers' Tacit Knowledge
Sylvia A Huisman, Kasper Kruithof, Maartje Hoogsteyns, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 24, 2010
Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo
Suzanne M Bal, Annelieke C Kruithof, Raphaël Zwier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1990
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells
J F Cajot, J Bamat, G E Bergonzelli, et al.
British Journal of Clinical Pharmacology
|
April 7, 2020
The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers
Sebastiaan C Goulooze, Annelieke C Kruithof, Shanavas Alikunju, et al.
Arthritis and Rheumatism
|
March 29, 2002
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy
Filip Van Den Bosch, Elli Kruithof, Dominique Baeten, et al.
Water Research
|
October 13, 2016
The role of natural organic matter in nitrite formation by LP-UV/H<sub>2</sub>O<sub>2</sub> treatment of nitrate-rich water
Sofia Semitsoglou-Tsiapou, Astrid Mous, Michael R Templeton, et al.
JACC. Basic to Translational Science
|
September 19, 2024
A New Ex Vivo Model to Study Cardiac Fibrosis in Whole Mouse Hearts
Boudewijn P T Kruithof, Babak Mousavi Gourabi, Arjanneke F van de Merbel, et al.
Page
of 50